Mental retardation. Behavior problems and psychotropic drugs. 1979

C B Rothman, and E Chusid, and M J Giannini

UI MeSH Term Description Entries
D008607 Intellectual Disability Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28) Disability, Intellectual,Idiocy,Mental Retardation,Retardation, Mental,Deficiency, Mental,Intellectual Development Disorder,Mental Deficiency,Mental Retardation, Psychosocial,Deficiencies, Mental,Development Disorder, Intellectual,Development Disorders, Intellectual,Disabilities, Intellectual,Disorder, Intellectual Development,Disorders, Intellectual Development,Intellectual Development Disorders,Intellectual Disabilities,Mental Deficiencies,Mental Retardations, Psychosocial,Psychosocial Mental Retardation,Psychosocial Mental Retardations,Retardation, Psychosocial Mental,Retardations, Psychosocial Mental
D011619 Psychotropic Drugs A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). Psychoactive Agent,Psychoactive Agents,Psychoactive Drug,Psychopharmaceutical,Psychopharmaceuticals,Psychotropic Drug,Psychoactive Drugs,Agent, Psychoactive,Agents, Psychoactive,Drug, Psychoactive,Drug, Psychotropic,Drugs, Psychoactive,Drugs, Psychotropic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001519 Behavior The observable response of a man or animal to a situation. Acceptance Process,Acceptance Processes,Behaviors,Process, Acceptance,Processes, Acceptance

Related Publications

C B Rothman, and E Chusid, and M J Giannini
January 1997, Bulletin de l'Academie nationale de medecine,
C B Rothman, and E Chusid, and M J Giannini
January 1998, Annales pharmaceutiques francaises,
C B Rothman, and E Chusid, and M J Giannini
October 1976, WHO chronicle,
C B Rothman, and E Chusid, and M J Giannini
April 2007, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
C B Rothman, and E Chusid, and M J Giannini
November 1971, Revue d'oto-neuro-ophtalmologie,
C B Rothman, and E Chusid, and M J Giannini
September 1995, American journal of mental retardation : AJMR,
C B Rothman, and E Chusid, and M J Giannini
January 1987, Therapie,
C B Rothman, and E Chusid, and M J Giannini
January 2005, The Milbank quarterly,
C B Rothman, and E Chusid, and M J Giannini
September 2004, Behavior modification,
Copied contents to your clipboard!